Corporate News     15-Mar-25 Zydus' Ankleshwar unit successfully completes USFDA inspection Zydus Lifesciences announced that the USFDA conducted a surveillance inspection at the group's API Unit 1, located at Ankleshwar in Gujarat. The inspection was conducted from 10 March to 14 March 2025. The inspection concluded with NIL observations. Previous News   Sentynl (Zydus Group) receives USFDA approval for ZYCUBO®  ( Corporate News - 13-Jan-26   14:01 )   Zydus Lifesciences’ US arm secures FDA nod for ZYCUBO in Pediatric Menkes Patients  ( Hot Pursuit - 13-Jan-26   11:17 )   Zydus Lifesciences Ltd spurts 0.27%, up for fifth straight session  ( Hot Pursuit - 06-Jan-26   13:00 )   Zydus partners with Bioeq for licensing, supply and commercialization of Lucentis® in US market  ( Corporate News - 23-Dec-25   19:05 )   Zydus signs agreement with Myriad Genetics  ( Corporate News - 19-Dec-25   10:22 )   Sentynl announces USFDA Acceptance of CUTX-101 NDA resubmission  ( Corporate News - 15-Dec-25   19:03 )   Zydus Lifesciences gains after launching Denosumab Biosimilar  ( Hot Pursuit - 10-Dec-25   11:27 )   Zydus launches Zyrifa - a Denosumab biosimilar  ( Corporate News - 10-Dec-25   10:19 )   Zydus Lifesciences receives EIR for facility at Jarod, Vadodara  ( Corporate News - 04-Dec-25   15:48 )   Zydus Life gets US FDA nod for generic version of antidiabetic combination drug Glyxambi  ( Hot Pursuit - 28-Nov-25   09:21 )   Zydus Life rises after inking exclusive licensing deal with RK Pharma for US oncology product  ( Hot Pursuit - 26-Nov-25   13:30 )	Other Stories   Comfort Intech to conduct board meeting   13-Jan-26   20:07   Netripples Software to hold board meeting   13-Jan-26   20:07   TCI Express schedules board meeting   13-Jan-26   20:06   Aarti Surfactants schedules board meeting   13-Jan-26   20:06   RBL Bank to convene board meeting   13-Jan-26   20:06   Equitas Small Finance Bank schedules board meeting   13-Jan-26   20:06   Indo US Bio-Tech to hold board meeting   13-Jan-26   20:06   Shoppers Stop to announce Quarterly Result   13-Jan-26   20:05   Tata Motors to discuss results   13-Jan-26   20:05   Viram Suvarn schedules board meeting   13-Jan-26   20:05
Back Top